- Home
- APVO vs GBR Comparison
APVO vs GBR Comparison
Compare APVO & GBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- GBR
- Stock Information
- Founded
- APVO 2016
- GBR 1978
- Country
- APVO United States
- GBR United States
- Employees
- APVO N/A
- GBR N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- GBR Oil & Gas Production
- Sector
- APVO Health Care
- GBR Energy
- Exchange
- APVO Nasdaq
- GBR Nasdaq
- Market Cap
- APVO 4.1M
- GBR 4.5M
- IPO Year
- APVO N/A
- GBR N/A
- Fundamental
- Price
- APVO $1.98
- GBR $0.90
- Analyst Decision
- APVO Strong Buy
- GBR
- Analyst Count
- APVO 1
- GBR 0
- Target Price
- APVO $5,920.00
- GBR N/A
- AVG Volume (30 Days)
- APVO 122.5K
- GBR 37.3K
- Earning Date
- APVO 08-11-2025
- GBR 08-12-2025
- Dividend Yield
- APVO N/A
- GBR N/A
- EPS Growth
- APVO N/A
- GBR N/A
- EPS
- APVO N/A
- GBR N/A
- Revenue
- APVO N/A
- GBR $151,000.00
- Revenue This Year
- APVO N/A
- GBR N/A
- Revenue Next Year
- APVO N/A
- GBR N/A
- P/E Ratio
- APVO N/A
- GBR N/A
- Revenue Growth
- APVO N/A
- GBR 4.14
- 52 Week Low
- APVO $1.72
- GBR $0.67
- 52 Week High
- APVO $381.10
- GBR $1.78
- Technical
- Relative Strength Index (RSI)
- APVO 32.74
- GBR 47.15
- Support Level
- APVO $1.87
- GBR $0.77
- Resistance Level
- APVO $2.07
- GBR $1.19
- Average True Range (ATR)
- APVO 0.18
- GBR 0.10
- MACD
- APVO 0.04
- GBR 0.01
- Stochastic Oscillator
- APVO 29.55
- GBR 30.93
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About GBR New Concept Energy Inc
New Concept Energy Inc is a United States-based company engaged in Real Estate Operations. It intends to continue to operate and or sell its West Virginia property. It provides advisory and management services for an independent West Virginia oil and gas company. The Company seeks to establish or acquire new business operations. It operates in one segment, which is real estate rental.